|
Number of patients (men/women)
|
48 (15/33)
|
|
Age (years)
|
64.2 ± 7.3
|
|
HD duration (years)
|
7.5 ± 7.3
|
|
Dry weight (kg)
|
61.3 ± 15.7
|
|
Disease
|
|
Diabetes mellitus
|
19
|
|
Chronic glomerulonephritis
|
12
|
|
Nephrosclerosis
|
3
|
|
ADPKD
|
6
|
|
Others
|
8
|
|
Comorbidities
|
|
Cardiovascular disease
|
0/48
|
|
Cerebrovascular disease
|
4/48
|
|
Medication, n (%)
|
|
Antihypertensive medicines
|
40 (83.3)
|
|
Renin-angiotensin system blocker
|
31 (64.6)
|
|
Calcium channel blocker
|
33 (68.8)
|
|
Beta blocker
|
12 (25.0)
|
|
Alpha blocker
|
8 (16.7)
|
|
Vitamin D analogue
|
39 (79.6)
|
|
Phosphate binder
|
41 (85.4)
|
|
Erythropoiesis-stimulating agent
|
46 (95.8)
|
|
Laboratory findings
|
|
Hb (g/dL)
|
10.9 ± 0.8
|
|
BUN (mg/dL)
|
67.4 ± 15.5
|
|
Serum creatinine (mg/dL)
|
11.3 ± 2.3
|
|
Na (mEq/L)
|
138.7 ± 1.7
|
|
K (mEq/L)
|
5.0 ± 0.7
|
|
Cl (mEq/L)
|
104.1 ± 2.7
|
|
Ca (mg/dL)
|
8.7 ± 0.6
|
|
P (mg/dL)
|
5.4 ± 1.3
|
|
Total protein (g/dL)
|
6.4 ± 0.4
|
|
Serum albumin (g/dL)
|
3.7 ± 0.3
|
| |
Standard HD
|
HD with BV-UFC
|
p-value
|
|
n (total number of HD sessions)
|
384
|
384
| |
|
Ultrafiltration (L/session)
|
2.80 ± 0.84
|
2.79 ± 0.80
|
0.780
|
|
Systolic blood pressure (mmHg)
|
151 ± 19
|
151 ± 19
|
0.933
|
|
Diastolic blood pressure (mmHg)
|
80 ± 11
|
80 ± 12
|
0.158
|
|
Heart rate (beats/min)
|
69.3 ± 9.3
|
69.8 ± 10.1
|
0.093
|
|
Kt/V urea
|
1.45 ± 0.25
|
1.48 ± 0.24
|
0.720
|
